-
EP1549346
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1549346
| EP1549346 - AMENDED RECOMBINANT CELLS (ARCS) FOR THE PRODUCTION AND DELIVERY OF ANTIVIRAL AGENTS, ADJUVANTS AND VACCINE ACCELERANTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.06.2012 Database last updated on 30.03.2026 | Most recent event Tooltip | 01.06.2012 | Application deemed to be withdrawn | published on 04.07.2012 [2012/27] | Applicant(s) | For all designated states Dow AgroSciences, LLC 9330 Zionsville Road Indianapolis Indiana 46268-1054 / US | [N/P] |
| Former [2005/27] | For all designated states Dow Agrosciences LLC 9330 Zionsville Road Indianapolis, Indiana 46268-1054 / US | Inventor(s) | 01 /
GAERTNER, Frank, H. 4461 Ocean Boulevard 36 San Diego, CA 92109 / US | 02 /
LEE, Stacey, Lynn 13831 Paseo Cardiel San Diego, CA 92129 / US | 03 /
SHUTTER, Robert, W. 14940 Cinchring Drive Poway, CA 92064 / US | [2005/27] | Representative(s) | Jappy, John William Graham Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street London EC2A 2ES / GB | [N/P] |
| Former [2008/39] | Jappy, John William Graham Gill Jennings & Every LLP Broadgate House 7 Eldon Street London EC2M 7LH / GB | ||
| Former [2005/27] | Jappy, John William Graham Gill Jennings & Every, Broadgate House, 7 Eldon Street London EC2M 7LH / GB | Application number, filing date | 03816565.0 | 07.10.2003 | [2005/27] | WO2003US31815 | Priority number, date | US20020417124P | 08.10.2002 Original published format: US 417124 P | [2005/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004087864 | Date: | 14.10.2004 | Language: | EN | [2004/42] | Type: | A2 Application without search report | No.: | EP1549346 | Date: | 06.07.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.10.2004 takes the place of the publication of the European patent application. | [2005/27] | Search report(s) | International search report - published on: | US | 23.12.2004 | (Supplementary) European search report - dispatched on: | EP | 25.03.2008 | Classification | IPC: | A61K45/00, C12N15/00 | [2005/27] | CPC: |
A61K38/217 (EP,US);
C12N15/00 (KR);
A61K35/00 (KR);
A61K39/39 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P31/04 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/04 (EP);
C12N1/00 (KR);
| Designated contracting states | DE, ES, FR, GB, IT [2006/04] |
| Former [2005/27] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | VERÄNDERTE REKOMBINANTE ZELLEN (ARCS) ZUR PRODUKTION UND ABGABE VON ANTIVIRALEN MITTELN, ADJUVANTIEN UND VAKZINE-BESCHLEUNIGER | [2005/27] | English: | AMENDED RECOMBINANT CELLS (ARCS) FOR THE PRODUCTION AND DELIVERY OF ANTIVIRAL AGENTS, ADJUVANTS AND VACCINE ACCELERANTS | [2005/27] | French: | CELLULES DE RECOMBINAISON MODIFIEES DESTINEES A LA PRODUCTION ET A L'ADMINISTRATION D'AGENTS ANTIVIRAUX, D'ADJUVANTS ET DE CATALYSEURS DE VACCIN | [2005/27] | Entry into regional phase | 21.04.2005 | National basic fee paid | 21.04.2005 | Search fee paid | 21.04.2005 | Designation fee(s) paid | 21.04.2005 | Examination fee paid | Examination procedure | 06.05.2004 | Request for preliminary examination filed International Preliminary Examining Authority: US | 11.04.2005 | Amendment by applicant (claims and/or description) | 21.04.2005 | Examination requested [2005/27] | 02.09.2011 | Despatch of a communication from the examining division (Time limit: M04) | 13.01.2012 | Application deemed to be withdrawn, date of legal effect [2012/27] | 20.02.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/27] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 02.09.2011 | Fees paid | Renewal fee | 09.03.2006 | Renewal fee patent year 03 | 12.10.2006 | Renewal fee patent year 04 | 12.10.2007 | Renewal fee patent year 05 | 14.10.2008 | Renewal fee patent year 06 | 13.10.2009 | Renewal fee patent year 07 | 12.10.2010 | Renewal fee patent year 08 | 11.10.2011 | Renewal fee patent year 09 | Penalty fee | Additional fee for renewal fee | 31.10.2005 | 03 M06 Fee paid on 09.03.2006 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] EP0168008 (TAKEDA CHEMICAL INDUSTRIES LTD et al.) [X] 1-6,29-34 * example 6 * | [T] GAERTNER ET AL: "Amended recombinant cells (ARCs(TM)): An economical and surprisingly effective production and delivery vehicle for recombinant bovine IFN-gamma", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 107, no. 2, 3 October 2005 (2005-10-03), pages 189 - 202, XP005076213, ISSN: 0168-3659 [T] 1-35 * abstract * * paragraph [02.1] - paragraph [02.2] * DOI: http://dx.doi.org/10.1016/j.jconrel.2005.06.008 |